Fox Chase Cancer Center News

Fox Chase Cancer Center’s Michael H. Levy, MD, PhD, Receives American Academy of Hospice and Palliative Medicine’s Lifetime Achievement Award

PHILADELPHIA (February 27, 2015)—Michael H. Levy, MD, PhD, Director of the Pain and Palliative Care Program at Fox Chase Cancer Center and one of the founding leaders of the American hospice and palliative care movement, has received the Lifetime Achievement Award from the American Academy of Hospice and Palliative Medicine (AAHPM) – a professional organization made up of 5,000 physicians, nurses and other healthcare providers, dedicated to advancing hospice and palliative medicine and improving the care of patients with life-threatening or serious conditions.

VIEW STORY

Fox Chase Cancer Center’s Radiation Oncology Department Earns Accreditation from the American College of Radiology

PHILADELPHIA (February 23, 2015)—Fox Chase Cancer Center’s Radiation Oncology Department, an international leader known for offering the latest advancements in radiation treatment, has earned accreditation from the American College of Radiology (ACR) for another three years at both its main campus in Northeast Philadelphia and Buckingham facility.

VIEW STORY

Fox Chase Cancer Center Receives Grant from National Breast Cancer Foundation for Community-Based Screening and Patient Navigation Services

PHILADELPHIA (February 3, 2015)—Fox Chase Cancer Center’s Office of Health Communications and Health Disparities (OHCHD) once again received a grant from the National Breast Cancer Foundation to fund community-based breast cancer screening and patient navigation services. Fox Chase has been fortunate to receive this one-year grant for the past three years. It allows OHCHD to reach underserved, uninsured women with mammography screening and navigation to follow-up services.

VIEW STORY

Fox Chase Researchers Reveal How Pancreatic Cancer Cells Sidestep Chemotherapy

PHILADELPHIA, PA (January 20, 2014)—Pancreatic cancer is one of the deadliest forms of the disease. The American Cancer Society’s most recent estimates for 2014 show that over 46,000 people will be diagnosed with pancreatic cancer and more than 39,000 will die from it. Now, research led by Timothy J. Yen, PhD, Professor at Fox Chase Cancer Center, reveals that one reason this deadly form of cancer can be so challenging to treat is because its cells have found a way to sidestep chemotherapy.

VIEW STORY